Astellas Transfers Three European Plants to Temmler Group

02-Jan-2007

Astellas Pharma Inc. announced that Temmler Group and Astellas have reached an agreement and concluded a contract providing for the transfer by Astellas of bulk assets comprising the Munich Plant and Klinge Ireland Plant of Astellas Deutschland GmbH, and all stocks of Produzioni Farmaceutiche Carugate S.r.l, to Temmler Group.

Astellas has previously declared in its mid-term 5-year management plan, ending in FY2010 (fiscal year ending March 2011), that the number of production sites will be reduced from the current 18 ( 9 in Japan and 9 overseas) to around 10 by FY2010 to achieve an optimal production system. This transfer of three plants has been effected in order to carry out this mid-term 5-year management plan.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance